BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 37483613)

  • 1. Diabetic complications and prospective immunotherapy.
    Reynolds L; Luo Z; Singh K
    Front Immunol; 2023; 14():1219598. PubMed ID: 37483613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-nutrient sensing pathways in diabetic complications.
    Parmar UM; Jalgaonkar MP; Kulkarni YA; Oza MJ
    Pharmacol Res; 2022 Oct; 184():106408. PubMed ID: 35988870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end-products and the progress of diabetic vascular complications.
    Jakus V; Rietbrock N
    Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advanced glycosylation end products and chronic complications of diabetes mellitus].
    Méndez JD
    Gac Med Mex; 2003; 139(1):49-55. PubMed ID: 12666409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Innate Immune and Inflammatory Responses in the Development of Secondary Diabetic Complications.
    Plowman TJ; Shah MH; Fernandez E; Christensen H; Aiges M; Ramana KV
    Curr Mol Med; 2023; 23(9):901-920. PubMed ID: 36154569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericytes in Type 2 Diabetes.
    Hayes KL
    Adv Exp Med Biol; 2019; 1147():265-278. PubMed ID: 31147882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
    Papachristoforou E; Lambadiari V; Maratou E; Makrilakis K
    J Diabetes Res; 2020; 2020():7489795. PubMed ID: 33123598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
    Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
    Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies.
    Adeshara KA; Diwan AG; Tupe RS
    Curr Drug Targets; 2016; 17(11):1309-28. PubMed ID: 26648059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.
    Babel RA; Dandekar MP
    Curr Diabetes Rev; 2021; 17(4):457-473. PubMed ID: 33143626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
    Khalid M; Petroianu G; Adem A
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tannins and vascular complications of Diabetes: An update.
    Laddha AP; Kulkarni YA
    Phytomedicine; 2019 Mar; 56():229-245. PubMed ID: 30668344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of diabetic complications: a chemical constituents based approach.
    Singh R; Kaur N; Kishore L; Gupta GK
    J Ethnopharmacol; 2013 Oct; 150(1):51-70. PubMed ID: 24041460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and Diabetic Complications: A Study from the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (NPPCD-2021) Implications for Action on Multiple Scales.
    Moosaie F; Ghaemi F; Mechanick JI; Shadnoush M; Firouzabadi FD; Kermanchi J; Poopak A; Esteghamati S; Forouzanfar R; Abhari SMF; Mansournia MA; Khosravi A; Gholami E; Nakhjavani M; Esteghamati A
    Prim Care Diabetes; 2022 Jun; 16(3):422-429. PubMed ID: 35396199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis.
    Lalla E; Lamster IB; Drury S; Fu C; Schmidt AM
    Periodontol 2000; 2000 Jun; 23():50-62. PubMed ID: 11276765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.